Donor-specific antibodies after ceasing immunosuppressive therapy, with or without an allograft nephrectomy.
Del Bello, Arnaud
Donor-specific antibodies after ceasing immunosuppressive therapy, with or without an allograft nephrectomy. [electronic resource] - Clinical journal of the American Society of Nephrology : CJASN Aug 2012 - 1310-9 p. digital
Publication Type: Comparative Study; Journal Article
1555-905X
10.2215/CJN.00260112 doi
Adult
Biopsy
Drug Administration Schedule
Female
France
Graft Rejection--immunology
Graft Survival--drug effects
HLA Antigens--immunology
Histocompatibility
Histocompatibility Testing--methods
Humans
Immunosuppressive Agents--administration & dosage
Isoantibodies--blood
Kidney Transplantation--adverse effects
Male
Middle Aged
Multivariate Analysis
Nephrectomy
Reoperation
Risk Assessment
Risk Factors
Time Factors
Treatment Outcome
Young Adult
Donor-specific antibodies after ceasing immunosuppressive therapy, with or without an allograft nephrectomy. [electronic resource] - Clinical journal of the American Society of Nephrology : CJASN Aug 2012 - 1310-9 p. digital
Publication Type: Comparative Study; Journal Article
1555-905X
10.2215/CJN.00260112 doi
Adult
Biopsy
Drug Administration Schedule
Female
France
Graft Rejection--immunology
Graft Survival--drug effects
HLA Antigens--immunology
Histocompatibility
Histocompatibility Testing--methods
Humans
Immunosuppressive Agents--administration & dosage
Isoantibodies--blood
Kidney Transplantation--adverse effects
Male
Middle Aged
Multivariate Analysis
Nephrectomy
Reoperation
Risk Assessment
Risk Factors
Time Factors
Treatment Outcome
Young Adult